|

Alectinib Oral Product Clinical Trials

1 actively recruiting trial

Also known as: Alecensa 150 mg Roche

Pipeline

Phase 1/2: 1

Top Sponsors

  • Instituto Nacional de Cancerologia de Mexico1

Indications

  • Non-small Cell Lung Cancer Stage IIIB1
  • ALK Gene Mutation1
  • Lung Cancer1
  • Cancer1

Other1 trial

Alectinib Pharmacokinetic in Patients With NSCLC
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.